A new trading day began on Tuesday, with Macrogenics Inc (NASDAQ: MGNX) stock price down -5.11% from the previous day of trading, before settling in for the closing price of $3.52. MGNX’s price has ranged from $2.95 to $21.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 15.77% over the last five years. Meanwhile, its annual earnings per share averaged -1238.85%. With a float of $58.01 million, this company’s outstanding shares have now reached $62.07 million.
The firm has a total of 339 workers. Let’s measure their productivity. In terms of profitability, gross margin is 73.82%, operating margin of -479.76%, and the pretax margin is -332.47%.
Macrogenics Inc (MGNX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Macrogenics Inc is 7.51%, while institutional ownership is 92.52%. The most recent insider transaction that took place on Apr 04 ’24, was worth 799,148. In this transaction Senior VP and General Counsel of this company sold 51,395 shares at a rate of $15.55, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 06 ’24, when Company’s Senior VP and General Counsel sold 19,625 for $21.50, making the entire transaction worth $421,938. This insider now owns 8,895 shares in total.
Macrogenics Inc (MGNX) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of 0.28 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1238.85% per share during the next fiscal year.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Here are Macrogenics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit 0.21 in the next quarter and is forecasted to reach -2.09 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Analysing the last 5-days average volume posted by the [Macrogenics Inc, MGNX], we can find that recorded value of 0.51 million was lower than the volume posted last year of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 4.81%. Additionally, its Average True Range was 0.22.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 13.80%, which indicates a significant increase from 0.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.96% in the past 14 days, which was lower than the 84.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.54, while its 200-day Moving Average is $8.86. Now, the first resistance to watch is $3.48. This is followed by the second major resistance level at $3.63. The third major resistance level sits at $3.70. If the price goes on to break the first support level at $3.26, it is likely to go to the next support level at $3.19. Now, if the price goes above the second support level, the third support stands at $3.04.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
With a market capitalization of 209.48 million, the company has a total of 62,722K Shares Outstanding. Currently, annual sales are 58,750 K while annual income is -9,060 K. The company’s previous quarter sales were 10,800 K while its latest quarter income was -55,660 K.
